A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and ...

Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...

In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive care options, covering treatments for acute myeloid leukemia (AML), ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

A new review by researchers at Oregon Health & Science University’s Knight Cancer Institute and other universities highlights how advances in New Approach Methodologies and tissue engineering are ...

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward ...

Oncoinvent ASA has completed a merger, resulting in the allocation of consideration shares to former shareholders, including primary insiders. This strategic move is expected to strengthen ...

Many cancer patients overlook crucial early warning signs, mistaking them for everyday issues. Oncologist Dr. Anchal Aggarwal ...

Texas A&M researchers have unlocked a new way to harness astatine-211, a rare and powerful isotope that may revolutionize ...

A controversial bill allowing terminally ill patients in Illinois to self-administer life-ending medication passed the ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...